SCHEMBL6766170

SCHEMBL6766170

CSc1ncc(C(=O)NCCc2ccccn2)c(Nc2ccc3cn[nH]c3c2)n1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 2/20 0.46
ROCK1 Q13464 2/20 0.45
GRK2 P25098 1/20 0.45
GRK5 P34947 1/20 0.45
SYK P43405 8/20 0.43
SMN1; SMN2 Q16637 1/20 0.42
DAPK3 O43293 2/20 0.42
PRKD3 O94806 2/20 0.42
MAP4K4 O95819 2/20 0.42
PAK4 O96013 2/20 0.42
PIM1 P11309 2/20 0.42
PRKACA P17612 2/20 0.42
CDK2 P24941 2/20 0.42
FLT3 P36888 2/20 0.42
CSNK1A1 P48729 2/20 0.42
CLK2 P49760 2/20 0.42
CDK9 P50750 2/20 0.42
JAK3 P52333 2/20 0.42
CDK5 Q00535 2/20 0.42
MAP4K2 Q12851 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6769259 0.93 ROCK1 (0.52) KDRROCK1GRK2GRK5SYK
SCHEMBL6608523 0.86 SYK (0.48) KDRROCK1SYKSMN1; SMN2DAPK3
SCHEMBL6770161 0.84 SYK (0.47) KDRSYKSMN1; SMN2DAPK3PRKD3
SCHEMBL6777397 0.84 SYK (0.46) KDRSYKDAPK3PRKD3MAP4K4
SCHEMBL6769860 0.81 SYK (0.52) KDRROCK1SYKSMN1; SMN2DAPK3
SCHEMBL6771569 0.81 LMNA (0.47) KDRROCK1SYKDAPK3PRKD3
SCHEMBL7077576 0.80 ROCK1 (0.55) KDRROCK1GRK2GRK5SYK
SCHEMBL6772485 0.80 HSD17B10 (0.46) SMN1; SMN2EGFRFLT1PDGFRBPDGFRA
SCHEMBL761284 0.79 SYK (0.54) KDRROCK1SYKDAPK3PRKD3
SCHEMBL6610211 0.79 SYK (0.55) KDRROCK1SYKDAPK3PRKD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6762189-B1 HEPATITIS B VIRUS AND HUMAN IMMUNODEFICIENCY VIRUS ANTIPROLIFERATION AGENTS; REDUCED CHANCE OF TOXICITY, SIDE EFFECTS, AND DEVELOPMENT OF RESISTANT VIRAL STRAINS DONG WHA PHARM. IND. CO., LTD. (KR) 2004-07-13 US disclosed